Eli Lilly has announced that Melissa Seymour will join the company as Executive Vice President, Global Quality and member of the Executive Committee, effective July 22, 2024.

Currently Director of Quality at Bristol Myers Squibb, Melissa Seymour will succeed Johna Norton, who is retiring after 34 years of service.

The laboratory points out that she has previously held management positions at Bristol Myers Squibb, Biogen, Novo Nordisk and Glaxo Smith Kline, and is thus recognized as a quality leader in the pharmaceutical industry.

David A. Ricks, Chief Executive Officer of Lilly, expressed his excitement at Melissa Seymour's arrival, highlighting her 25 years of experience and expertise in strategic quality initiatives.


Copyright (c) 2024 CercleFinance.com. All rights reserved.